Supporting antibody quantification in biologic development

Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases.

In this application note, Abselion demonstrates the Amperia™ platform, offering a streamlined alternative, enabling consistent, sensor-based mAb quantification directly from cell culture supernatants using an inverse occupancy assay format, with adaptable throughput and simplified setup.